本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Cogent Biosciences, Inc.

6.90
+0.10001.47%
盘后6.930.0300+0.43%18:23 EDT
成交量:222.14万
成交额:1,511.76万
市值:7.86亿
市盈率:-3.39
高:7.07
开:6.99
低:6.59
收:6.80
数据加载中...
2022/03/17

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/15

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/15

重要事件披露

8-K - Current report
2022/03/01

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/25

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/27

重要事件披露

8-K - Current report
2021/10/05

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/05

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/07/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/06/17

重要事件披露

8-K - Current report
2021/05/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/12

重要事件披露

8-K - Current report
2021/03/16

SEC问询函

CORRESP [Cover] - Correspondence